Skip to content

Commit f86cdba

Browse files
committed
fixup! 换来源
我服了这个 lynch mm 怎么写这么多东西,还搞了个不在 pubmed 里面的 Signed-off-by: Mingye Wang <[email protected]>
1 parent f562cab commit f86cdba

File tree

1 file changed

+1
-1
lines changed
  • content/zh-cn/docs/medicine/antiandrogen/medroxyprogesterone

1 file changed

+1
-1
lines changed

Diff for: content/zh-cn/docs/medicine/antiandrogen/medroxyprogesterone/index.md

+1-1
Original file line numberDiff line numberDiff line change
@@ -89,5 +89,5 @@ description: 醋酸甲羟孕酮(Medroxyprogesterone Acetate),是一种类
8989
[^11]: Aly. An Introduction to Hormone Therapy for Transfeminine People [EB/OL]. *Transfeminine Science*, 2018. 译文:《[女性倾向跨性别者的激素治疗简介](https://tfsci.mtf.wiki/articles/transfem-intro/)
9090
[^12]: Meyer W J, Walker P A, Emory L E, et al. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate [J]. *Fertility and Sterility*, 1985, 43(1): 102-109. DOI: [10.1016/S0015-0282(16)48326-3](https://www.sciencedirect.com/science/article/pii/S0015028216483263)
9191
[^13]: Pfizer. Prescribing Information: PROVERA&reg; [EB/OL]. Drugs@FDA, 2024. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011839s083lbl.pdf>[译文](https://tfsci.mtf.wiki/misc/provera/)
92-
[^14]: Jain J, Kwan D, Forcier M. Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5148-5156. doi: [10.1210/jc.2018-02253](https://academic.oup.com/jcem/article/104/11/5148/5479358). PMID: 31127826.
92+
[^14]: Lynch, M. M., Khandheria, M. M., & Meyer, W. J. (2015). Retrospective Study of the Management of Childhood and Adolescent Gender Identity Disorder Using Medroxyprogesterone Acetate. International Journal of Transgenderism, 16(4), 201–208. https://doi.org/10.1080/15532739.2015.1080649
9393
[^15]: Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin North Am. 1990 Dec;37(6):1255-71. doi: 10.1016/s0031-3955(16)37010-9. PMID: 2147987.

0 commit comments

Comments
 (0)